Nixon Peabody Trust Co. Sells 3,425 Shares of Procter & Gamble Company (The) $PG

Nixon Peabody Trust Co. decreased its position in Procter & Gamble Company (The) (NYSE:PG) by 3.5% in the first quarter, Holdings Channel.com reports. The firm owned 94,705 shares of the company’s stock after selling 3,425 shares during the quarter. Procter & Gamble comprises approximately 1.1% of Nixon Peabody Trust Co.’s investment portfolio, making the stock its 27th largest position. Nixon Peabody Trust Co.’s holdings in Procter & Gamble were worth $13,679,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also added to or reduced their stakes in PG. E Fund Management Hong Kong Co. Ltd. boosted its stake in Procter & Gamble by 1,000.0% during the fourth quarter. E Fund Management Hong Kong Co. Ltd. now owns 165 shares of the company’s stock worth $25,000 after acquiring an additional 150 shares in the last quarter. Litman Gregory Wealth Management LLC bought a new position in shares of Procter & Gamble during the fourth quarter valued at approximately $26,000. Park Square Financial Group LLC increased its stake in shares of Procter & Gamble by 65.1% during the fourth quarter. Park Square Financial Group LLC now owns 180 shares of the company’s stock valued at $26,000 after purchasing an additional 71 shares in the last quarter. Evolution Wealth Management Inc. lifted its holdings in shares of Procter & Gamble by 1,315.4% during the fourth quarter. Evolution Wealth Management Inc. now owns 184 shares of the company’s stock valued at $26,000 after purchasing an additional 171 shares during the last quarter. Finally, Basso Capital Management L.P. purchased a new position in shares of Procter & Gamble during the fourth quarter valued at approximately $28,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Procter & Gamble Trading Down 0.1%

NYSE:PG opened at $151.30 on Friday. The stock has a market cap of $352.32 billion, a price-to-earnings ratio of 22.12, a PEG ratio of 6.44 and a beta of 0.39. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.44. The company’s 50 day moving average price is $146.45 and its 200-day moving average price is $148.25. Procter & Gamble Company has a 52 week low of $137.62 and a 52 week high of $167.25.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings data on Friday, April 24th. The company reported $1.59 earnings per share for the quarter, topping analysts’ consensus estimates of $1.56 by $0.03. Procter & Gamble had a net margin of 19.16% and a return on equity of 32.00%. The company had revenue of $21.23 billion during the quarter, compared to analyst estimates of $21.52 billion. During the same period in the previous year, the business earned $1.54 EPS. The firm’s revenue for the quarter was up 7.4% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, equities research analysts forecast that Procter & Gamble Company will post 6.9 earnings per share for the current fiscal year.

Procter & Gamble Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, May 15th. Stockholders of record on Friday, April 24th were paid a $1.0885 dividend. This is an increase from Procter & Gamble’s previous quarterly dividend of $1.06. This represents a $4.35 annualized dividend and a dividend yield of 2.9%. The ex-dividend date was Friday, April 24th. Procter & Gamble’s dividend payout ratio (DPR) is presently 63.60%.

Analysts Set New Price Targets

Several analysts recently weighed in on PG shares. BMO Capital Markets upped their price target on Procter & Gamble from $169.00 to $170.00 and gave the stock an “outperform” rating in a research note on Monday, June 29th. JPMorgan Chase & Co. lowered their price objective on Procter & Gamble from $165.00 to $162.00 and set an “overweight” rating for the company in a research note on Friday, April 17th. Raymond James Financial cut their target price on Procter & Gamble from $175.00 to $170.00 and set an “outperform” rating on the stock in a research note on Tuesday, April 14th. UBS Group raised their price target on Procter & Gamble from $166.00 to $172.00 and gave the company a “buy” rating in a report on Monday, April 27th. Finally, Jefferies Financial Group lifted their price target on Procter & Gamble from $177.00 to $179.00 and gave the stock a “buy” rating in a research report on Friday, June 26th. Twelve research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $161.47.

About Procter & Gamble

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.